Skip to main content
. 2021 Dec 4;12(2):11784–11796. doi: 10.1080/21655979.2021.1996508

Figure 6.

Figure 6.

RANKL inhibited the effects of BBR+Rb1 on adipogenesis and insulin resistance in TNF-α-treated adipocytes. (a) Adipogenesis was evaluated by performing oil red O staining assay (**, p < 0.01, compared to Control; ##, p < 0.01, compared to TNF-α; &&, p < 0.05, compared to BBR+Rb1). (b) The gene and protein expression levels of PPAR-γ, C/EBPα, and SREBP-1 c were measured in RT-PCR and western blot assays, respectively (**, p < 0.01, compared to Control; ##, p < 0.01, compared to TNF-α; &&, p < 0.05, compared to BBR+Rb1). (c) The gene and protein expression levels of IRS-1 and GLUT4 were measured in RT-PCR and western blot assays, respectively (**, p < 0.01, compared to Control; ##, p < 0.01, compared to TNF-α; &&, p < 0.01, compared to BBR+Rb1)